Literature DB >> 21686853

Extracorporeal elimination in acute valproate intoxication.

Els A van der Wouden1, Angela Dekkers, Hannah M E Kruis, Ingeborg M van Geijlswijk, David H Tjan, Geert W Feith.   

Abstract

Severe poisoning with valproate may result in coma and death. The management of valproate intoxication is principally supportive. Valproate is scarcely excreted renally and is mainly protein bound and, therefore, not considered to be amenable for extracorporeal elimination. Despite these unfavourable pharmacokinetic properties, several case reports showed successful treatment of valproate intoxication with haemodialysis and/or haemoperfusion. We describe a male patient (57 years) after ingestion of 64 g of valproate. The patient was successfully treated with haemodialysis for 6 h. Haemodialysis was followed by continuous venovenous haemodiafiltration (CVVH-D) for 18 h to prevent a rebound phenomenon. This report confirms the benefit of haemodialysis in serious valproate overdose. A review of the literature shows that haemodialysis followed by CVVH-D is the treatment of choice in severe valproate intoxication.

Entities:  

Year:  2009        PMID: 21686853      PMCID: PMC3029326          DOI: 10.1136/bcr.06.2008.0337

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  14 in total

Review 1.  Valproic acid overdose and haemodialysis.

Authors:  L K Hicks; P A McFarlane
Journal:  Nephrol Dial Transplant       Date:  2001-07       Impact factor: 5.992

Review 2.  Valproic acid toxicity: overview and management.

Authors:  Matthew D Sztajnkrycer
Journal:  J Toxicol Clin Toxicol       Date:  2002

3.  Simultaneous "in series" hemodialysis and hemoperfusion in the management of valproic acid overdose.

Authors:  J E Tank; B F Palmer
Journal:  Am J Kidney Dis       Date:  1993-08       Impact factor: 8.860

4.  High-flux hemodialysis without hemoperfusion is effective in acute valproic acid overdose.

Authors:  S L Kane; M Constantiner; A E Staubus; C D Meinecke; J R Sedor
Journal:  Ann Pharmacother       Date:  2000-10       Impact factor: 3.154

5.  Valproic acid toxicokinetics: serial hemodialysis and hemoperfusion.

Authors:  E J Franssen; G G van Essen; A T Portman; J de Jong; G Go; C A Stegeman; D R Uges
Journal:  Ther Drug Monit       Date:  1999-06       Impact factor: 3.681

Review 6.  Extracorporeal management of valproic acid toxicity: a case report and review of the literature.

Authors:  Ziyad Al Aly; Praveen Yalamanchili; Esther Gonzalez
Journal:  Semin Dial       Date:  2005 Jan-Feb       Impact factor: 3.455

7.  Valproic acid intoxication: sense and non-sense of haemodialysis.

Authors:  M F Meek; J Broekroelofs; J P Yska; P H M Egbers; E C Boerma; P H J van der Voort
Journal:  Neth J Med       Date:  2004-10       Impact factor: 1.422

8.  Hemodialysis versus continuous veno-venous hemodiafiltration in the management of severe valproate overdose.

Authors:  T D Kay; H R Playford; D W Johnson
Journal:  Clin Nephrol       Date:  2003-01       Impact factor: 0.975

Review 9.  Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society.

Authors:  J A French; A M Kanner; J Bautista; B Abou-Khalil; T Browne; C L Harden; W H Theodore; C Bazil; J Stern; S C Schachter; D Bergen; D Hirtz; G D Montouris; M Nespeca; B Gidal; W J Marks; W R Turk; J H Fischer; B Bourgeois; A Wilner; R E Faught; R C Sachdeo; A Beydoun; T A Glauser
Journal:  Neurology       Date:  2004-04-27       Impact factor: 9.910

10.  The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial.

Authors:  Anthony G Marson; Asya M Al-Kharusi; Muna Alwaidh; Richard Appleton; Gus A Baker; David W Chadwick; Celia Cramp; Oliver C Cockerell; Paul N Cooper; Julie Doughty; Barbara Eaton; Carrol Gamble; Peter J Goulding; Stephen J L Howell; Adrian Hughes; Margaret Jackson; Ann Jacoby; Mark Kellett; Geoffrey R Lawson; John Paul Leach; Paola Nicolaides; Richard Roberts; Phil Shackley; Jing Shen; David F Smith; Philip E M Smith; Catrin Tudur Smith; Alessandra Vanoli; Paula R Williamson
Journal:  Lancet       Date:  2007-03-24       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.